Interestingly, fetuin-A levels were higher in CAD patients and associated with NAFLD but not in PAD patients suggesting that the crosstalk between fetuin-A, NAFLD and atherosclerosis varies according to the arterial site [17]. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.